{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:30:54Z","timestamp":1790400654688,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Selma Kron Foundation, USA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jaut.2020.102462","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T08:54:46Z","timestamp":1586508886000},"page":"102462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells"],"prefix":"10.1016","volume":"112","author":[{"given":"Mia","family":"Levite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nili","family":"Ilouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raya","family":"Eilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally Ahmed","family":"Ramadhan Lasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagit","family":"Arbel-Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Edvardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tarshish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lul P.","family":"Riek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Lino","family":"Lako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Reubinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lebendiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayana","family":"Yaish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Stavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithan","family":"Galun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2020.102462_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.pt.2016.05.013","article-title":"Nodding syndrome in onchocerciasis endemic areas","volume":"32","author":"Colebunders","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jaut.2020.102462_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6953","article-title":"Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus","volume":"9","author":"Johnson","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2020.102462_bib3","first-page":"205","article-title":"Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature","volume":"13","author":"Musisi","year":"2013","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.jaut.2020.102462_bib4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1528-1167.2008.01671.x","article-title":"The head nodding syndrome--clinical classification and possible causes","volume":"49","author":"Winkler","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaut.2020.102462_bib5","first-page":"529","article-title":"MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study","volume":"13","author":"Winkler","year":"2013","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.jaut.2020.102462_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-018-1909-9","article-title":"Nodding syndrome in Uganda is a tauopathy","volume":"136","author":"Pollanen","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jaut.2020.102462_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnen\/nlz090","article-title":"Neuroinflammation and not tauopathy is a predominant pathological signature of nodding syndrome","volume":"78","author":"Hotterbeekx","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jaut.2020.102462_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s11064-006-9143-6","article-title":"Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels","volume":"31","author":"Cohen-Kashi Malina","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jaut.2020.102462_bib9","first-page":"241","article-title":"Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy","volume":"11","author":"Ganor","year":"2004","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jaut.2020.102462_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.psyneuen.2014.01.005","article-title":"Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA\/2J mice, lower seizure threshold and induce abnormal behavior","volume":"42","author":"Ganor","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jaut.2020.102462_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eplepsyres.2005.03.011","article-title":"Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate\/AMPA receptor GluR3, glutamate\/NMDA receptor subunit NR2A or double-stranded DNA","volume":"65","author":"Ganor","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jaut.2020.102462_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.expneurol.2005.04.002","article-title":"Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures","volume":"195","author":"Ganor","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jaut.2020.102462_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psyneuen.2013.11.007","article-title":"Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) associate with some cognitive\/psychiatric\/behavioral abnormalities in epilepsy patients","volume":"40","author":"Goldberg-Stern","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jaut.2020.102462_bib14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.8036512","article-title":"Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis","volume":"265","author":"Rogers","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jaut.2020.102462_bib15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0896-6273(95)90219-8","article-title":"Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site","volume":"14","author":"Twyman","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2020.102462_bib16","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1523\/JNEUROSCI.20-19-07307.2000","article-title":"GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins","volume":"20","author":"Whitney","year":"2000","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jaut.2020.102462_bib17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.57.8.1511","article-title":"GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis","volume":"57","author":"Wiendl","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2020.102462_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0959-4388(96)80102-4","article-title":"Rasmussen's encephalitis: an autoimmune disorder?","volume":"6","author":"Andrews","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jaut.2020.102462_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0896-6273(00)80443-2","article-title":"Glutamate receptor GluR3 antibodies and death of cortical cells","volume":"20","author":"He","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2020.102462_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00702-014-1193-3","volume":"121","author":"Levite","year":"2014","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.jaut.2020.102462_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(03)00252-2","article-title":"Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders","volume":"141","author":"Tanaka","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2020.102462_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.coph.2008.05.001","article-title":"Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors","volume":"8","author":"Levite","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jaut.2020.102462_bib23","first-page":"359","article-title":"Nerve driven immunity: neurotransmitters and neuropeptides in the immune system","author":"Levite","year":"2012"},{"key":"10.1016\/j.jaut.2020.102462_bib24","series-title":"Reactive Oxygen Species in Status Epilepticus","first-page":"106410","author":"Shekh-Ahmad","year":"2019"},{"key":"10.1016\/j.jaut.2020.102462_bib25","doi-asserted-by":"crossref","first-page":"106275","DOI":"10.1016\/j.yebeh.2019.04.028","article-title":"Inflammation and reactive oxygen species in status epilepticus: biomarkers and implications for therapy","author":"Terrone","year":"2019","journal-title":"Epilepsy Behav. : E&B"},{"key":"10.1016\/j.jaut.2020.102462_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/jaut.1999.0301","article-title":"Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel","volume":"13","author":"Levite","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102462_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/jaut.1999.0297","article-title":"Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?","volume":"13","author":"Levite","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102462_bib28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1586\/14737175.8.7.1141","article-title":"Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis","volume":"8","author":"Levite","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jaut.2020.102462_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2020.102462_bib30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2020.102462_bib31","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1460-9568.2008.06078.x","article-title":"GluR3 subunit regulates sleep, breathing and seizure generation","volume":"27","author":"Steenland","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jaut.2020.102462_bib32","doi-asserted-by":"crossref","first-page":"23786","DOI":"10.1074\/jbc.M301360200","article-title":"Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by gamma-secretase","volume":"278","author":"Meyer","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2020.102462_bib33","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.4049\/jimmunol.170.8.4362","article-title":"Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration","volume":"170","author":"Ganor","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102462_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00702-014-1167-5","article-title":"The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells","volume":"121","author":"Ganor","year":"2014","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.jaut.2020.102462_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1474-4422(12)70321-6","article-title":"Clinical, neurological, and electrophysiological features of nodding syndrome in Kitgum, Uganda: an observational case series","volume":"12","author":"Sejvar","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2020.102462_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002540","article-title":"Nodding syndrome in Ugandan children--clinical features, brain imaging and complications: a case series","volume":"3","author":"Idro","year":"2013","journal-title":"BMJ open"},{"key":"10.1016\/j.jaut.2020.102462_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1258\/td.2010.090373","article-title":"Clinical characteristics of people with head nodding in southern Tanzania","volume":"40","author":"Winkler","year":"2010","journal-title":"Trop. Doct."},{"key":"10.1016\/j.jaut.2020.102462_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cne.10710","article-title":"Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus","volume":"462","author":"Moga","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jaut.2020.102462_bib39","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1074\/jbc.272.17.11295","article-title":"Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation","volume":"272","author":"Carlson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2020.102462_bib40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jnr.1042","article-title":"Identification of the amino acids on a neuronal glutamate receptor recognized by an autoantibody from a patient with paraneoplastic syndrome","volume":"63","author":"Carlson","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.jaut.2020.102462_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni0602-500","article-title":"Autoimmune epilepsy","volume":"3","author":"Levite","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102462_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008436","article-title":"Protection or susceptibility to devastating childhood epilepsy: Nodding Syndrome associates with immunogenetic fingerprints in the HLA binding groove","author":"Benedek","year":"2020","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120300780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120300780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:26:04Z","timestamp":1760257564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841120300780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":42,"alternative-id":["S0896841120300780"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102462","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102462"}}